These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 9472045)

  • 1. Vascular endothelial growth factor induces endothelial fenestrations in vitro.
    Esser S; Wolburg K; Wolburg H; Breier G; Kurzchalia T; Risau W
    J Cell Biol; 1998 Feb; 140(4):947-59. PubMed ID: 9472045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-induced permeability increase is mediated by caveolae.
    Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.
    Liu J; Razani B; Tang S; Terman BI; Ware JA; Lisanti MP
    J Biol Chem; 1999 May; 274(22):15781-5. PubMed ID: 10336480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels.
    Vasile E; Qu-Hong ; Dvorak HF; Dvorak AM
    J Histochem Cytochem; 1999 Feb; 47(2):159-67. PubMed ID: 9889252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells.
    Feng Y; Venema VJ; Venema RC; Tsai N; Caldwell RB
    Biochem Biophys Res Commun; 1999 Mar; 256(1):192-7. PubMed ID: 10066445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression and localization of vascular endothelial growth factor and its receptors in the human epididymis.
    Ergün S; Luttmer W; Fiedler W; Holstein AF
    Biol Reprod; 1998 Jan; 58(1):160-8. PubMed ID: 9472937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors.
    Marti HH; Risau W
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15809-14. PubMed ID: 9861052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF?
    Villars F; Bordenave L; Bareille R; Amédée J
    J Cell Biochem; 2000 Sep; 79(4):672-85. PubMed ID: 10996857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
    Mandriota SJ; Pepper MS
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2293-302. PubMed ID: 9378778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells.
    Chen J; Braet F; Brodsky S; Weinstein T; Romanov V; Noiri E; Goligorsky MS
    Am J Physiol Cell Physiol; 2002 May; 282(5):C1053-63. PubMed ID: 11940521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF spatially directs angiogenesis during metanephric development in vitro.
    Tufró A
    Dev Biol; 2000 Nov; 227(2):558-66. PubMed ID: 11071774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
    Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
    Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells.
    Amemiya T; Sasamura H; Mifune M; Kitamura Y; Hirahashi J; Hayashi M; Saruta T
    Kidney Int; 1999 Dec; 56(6):2055-63. PubMed ID: 10594781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
    Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
    Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.
    Yamagishi S; Yonekura H; Yamamoto Y; Fujimori H; Sakurai S; Tanaka N; Yamamoto H
    Lab Invest; 1999 Apr; 79(4):501-9. PubMed ID: 10212003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.